Zinc-alpha(2)-glycoprotein hinders cell proliferation and reduces cdc2 expression

Area of Science:

• Biochemistry
• Cell Biology
• Oncology

Background:

• Zinc-alpha(2)-glycoprotein (Znα(2)gp) is found in body fluids and epithelia, with increased expression during epithelial differentiation.
• Previous studies indicated Znα(2)gp possesses ribonuclease activity and can inhibit squamous tumor cell growth.
• Znα(2)gp's role in tumor cell proliferation requires further elucidation.

Purpose of the Study:

• To investigate the effect of Znα(2)gp on SiHa tumor cell proliferation and cell cycle progression.
• To determine the molecular mechanisms underlying Znα(2)gp-mediated growth inhibition.
• To assess Znα(2)gp's impact on key cell cycle regulatory genes.

Main Methods:

• SiHa cells were treated with Znα(2)gp in culture medium and via stable transfection with Znα(2)gp cDNA.
• Cell proliferation was assessed, and cell cycle distribution was analyzed using flow cytometry.
• Gene expression changes were examined using RT-PCR, focusing on markers of apoptosis, differentiation, and cell cycle regulation (PCNA, p53, c-myc, bcl-2, cdc2).

Main Results:

• Introduction of Znα(2)gp into SiHa cells significantly reduced proliferation.
• Flow cytometry revealed an accumulation of cells in the G2/M phase, correlating with reduced proliferation.
• RT-PCR analysis showed no significant changes in PCNA, p53, c-myc, or bcl-2 expression, but demonstrated a reduction in cdc2 expression by over 50%.

Conclusions:

• Znα(2)gp effectively inhibits SiHa tumor cell proliferation.
• The antiproliferative effect is associated with G2/M cell cycle arrest.
• Downregulation of cdc2 expression by Znα(2)gp may be a key mechanism hindering tumor progression.